NATICK, Mass. -- The 13th Annual Future Workforce Poster Presentation took place at the U.S. Army Combat Capabilities Development Command Soldier Center on August 15. The event showcased the CCDC ...
-- Poster presentation of MGTA-145 investigator-initiated Phase 2 clinical trial data confirmed previously reported positive topline clinical data for stem cell mobilization and transplant in multiple ...
GENESIS (NCT 03246529) is a 2-part, Phase-3, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of APHEXDA (motixafortide) plus filgrastim (G-CSF), ...
Satellos Bioscience Inc. (Nasdaq: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, ...
On November 13th and 14th, 2020 the Wyoming Research Scholars Program held it's first ever Virtual Symposium. For this online conference, WRSP undergraduate fellows uploaded their presentations on ...
Four platform presentations and two posters on the company’s clinical and preclinical programs for lysosomal disorders are scheduled throughout 17th annual WORLDSymposium™ The company also will host ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results